Overall, this work highlighted that sorcin (1) activates the PMCA by its binding to it, and (2) interacts with two key molecular markers of AD, such as Aβ and tau, blocking their inhibitory effects on PMCA. This evidence concerns the gene MAPT and Alzheimer disease.